Association of Genomic Domains in


Journal

Cancer research
ISSN: 1538-7445
Titre abrégé: Cancer Res
Pays: United States
ID NLM: 2984705R

Informations de publication

Date de publication:
01 02 2020
Historique:
received: 01 07 2019
revised: 07 08 2019
accepted: 08 11 2019
pubmed: 15 11 2019
medline: 18 8 2020
entrez: 15 11 2019
Statut: ppublish

Résumé

Pathogenic sequence variants (PSV) in

Identifiants

pubmed: 31723001
pii: 0008-5472.CAN-19-1840
doi: 10.1158/0008-5472.CAN-19-1840
pmc: PMC7553241
mid: NIHMS1628039
doi:

Substances chimiques

BRCA1 Protein 0
BRCA1 protein, human 0
BRCA2 Protein 0
BRCA2 protein, human 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

624-638

Subventions

Organisme : NCI NIH HHS
ID : P20 CA233255
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA140323
Pays : United States
Organisme : Cancer Research UK
ID : C12292/A11174
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C5047/A10692
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C5047/A8384
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C1287/A 10710
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P50 CA116201
Pays : United States
Organisme : Cancer Research UK
ID : C5047/A15007
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 10118
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C1281/A12014
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C12292/A11174
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : P30 CA008748
Pays : United States
Organisme : Cancer Research UK
ID : C5047/A8385FCCC
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C12292/A20861
Pays : United Kingdom
Organisme : NIGMS NIH HHS
ID : P20 GM130423
Pays : United States
Organisme : Cancer Research UK
ID : C8197/A16565
Pays : United Kingdom
Organisme : NCI NIH HHS
ID : R01 CA192393
Pays : United States

Commentaires et corrections

Type : CommentIn

Informations de copyright

©2019 American Association for Cancer Research.

Références

JAMA. 2017 Jun 20;317(23):2402-2416
pubmed: 28632866
J Clin Oncol. 2018 Feb 1;36(4):414-424
pubmed: 29236593
Clin Cancer Res. 2007 Feb 1;13(3):839-43
pubmed: 17289875
J Natl Cancer Inst. 2007 Jun 20;99(12):929-35
pubmed: 17565157
FASEB J. 1997 Jan;11(1):68-76
pubmed: 9034168
Can Urol Assoc J. 2014 Nov;8(11-12):E783-8
pubmed: 25485004
Prostate. 2016 Sep;76(13):1135-45
pubmed: 27225637
Nat Genet. 1995 Dec;11(4):428-33
pubmed: 7493024
Breast Cancer Res. 2005;7(1):R93-100
pubmed: 15642173
J Mol Med (Berl). 1997 Oct;75(10):758-61
pubmed: 9383000
Oncogene. 2002 Jun 13;21(26):4171-5
pubmed: 12037674
J Clin Oncol. 2004 Feb 15;22(4):735-42
pubmed: 14966099
Cell. 2015 May 21;161(5):1215-1228
pubmed: 26000489
Hered Cancer Clin Pract. 2015 Aug 01;13(1):16
pubmed: 26236408
J Clin Oncol. 2013 May 10;31(14):1748-57
pubmed: 23569316
Nat Struct Biol. 2001 Oct;8(10):838-42
pubmed: 11573086
Nat Genet. 1997 Jan;15(1):103-5
pubmed: 8988179
Acta Oncol. 2016;55(1):38-44
pubmed: 26360800
Hum Mutat. 2006 Nov;27(11):1122-8
pubmed: 16958054
Eur J Hum Genet. 2001 Oct;9(10):773-9
pubmed: 11781689
Eur Urol. 2014 Sep;66(3):489-99
pubmed: 24484606
Brief Funct Genomics. 2013 Jan;12(1):25-36
pubmed: 23148322
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3352-7
pubmed: 10737795
J Med Genet. 2003 Oct;40(10):787-92
pubmed: 14569130
Mutat Res. 2000 Aug 30;460(3-4):319-32
pubmed: 10946236
Br J Cancer. 2013 Jun 25;108(12):2601-9
pubmed: 23722471
JAMA. 2015 Apr 7;313(13):1347-61
pubmed: 25849179
Hum Mol Genet. 2002 Nov 1;11(23):2805-14
pubmed: 12393792
Oncologist. 2016 Jul;21(7):869-74
pubmed: 27306910
Cancer Causes Control. 2010 Feb;21(2):289-300
pubmed: 19902366
Prostate. 2014 Oct;74(14):1444-51
pubmed: 25111659
Am J Hum Genet. 2001 Feb;68(2):410-9
pubmed: 11170890
Clin Cancer Res. 2010 Apr 1;16(7):2115-21
pubmed: 20215531
Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4036-41
pubmed: 17360473
Breast Cancer Res Treat. 2015 Apr;150(3):631-5
pubmed: 25788227
Hum Mutat. 2006 Oct;27(10):1024-9
pubmed: 16941470
Clin Cancer Res. 2009 Feb 1;15(3):1112-20
pubmed: 19188187
Nat Struct Biol. 2001 Oct;8(10):833-7
pubmed: 11573085
Nat Genet. 1996 Dec;14(4):430-40
pubmed: 8944023
Breast Cancer Res. 2007;9(2):104
pubmed: 17466083
Crit Rev Oncol Hematol. 2007 Feb;61(2):153-61
pubmed: 17064931
Clin Cancer Res. 2004 May 1;10(9):2918-21
pubmed: 15131025
Nat Genet. 2018 May;50(5):645-651
pubmed: 29610475
Cancer Res. 1995 Nov 1;55(21):4830-2
pubmed: 7585515
Nat Commun. 2017 Jan 09;8:13671
pubmed: 28067867
Am J Hum Genet. 2004 Oct;75(4):535-44
pubmed: 15290653
Cancer Res. 1996 Jun 1;56(11):2539-45
pubmed: 8653694
Br J Cancer. 2012 May 8;106(10):1697-701
pubmed: 22516946
Br J Cancer. 2007 Sep 17;97(6):826-31
pubmed: 17700570
Cancer. 2014 Jul 1;120(13):1920-31
pubmed: 24699901
Cancer Prev Res (Phila). 2011 Jul;4(7):1002-10
pubmed: 21733824
Breast Cancer Res. 2004;6(4):R284-90
pubmed: 15217494
Br J Cancer. 2011 Oct 11;105(8):1230-4
pubmed: 21952622

Auteurs

Vivek L Patel (VL)

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.

Evan L Busch (EL)

Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

Tara M Friebel (TM)

Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
Dana-Farber Cancer Institute. Boston, Massachusetts.

Angel Cronin (A)

Dana-Farber Cancer Institute. Boston, Massachusetts.

Goska Leslie (G)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Lesley McGuffog (L)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Julian Adlard (J)

Yorkshire Regional Genetics Service, Chapel Allerton Hospital, Leeds, United Kingdom.

Simona Agata (S)

Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.

Bjarni A Agnarsson (BA)

Department of Pathology, Landspitali University Hospital, 101, Reykjavik, Iceland.
School of Medicine, University of Iceland, Reykjavik, Iceland.

Munaza Ahmed (M)

North East Thames Regional Genetics Service, Great Ormond Street Hospital for Children NHS Trust, London, United Kingdom.

Kristiina Aittomäki (K)

Department of Clinical Genetics, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Elisa Alducci (E)

Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.

Irene L Andrulis (IL)

Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.
Department of Molecular Genetics, University of Toronto, Toronto, Ontario, Canada.

Adalgeir Arason (A)

Department of Pathology, Landspitali University Hospital, 101, Reykjavik, Iceland.
BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Norbert Arnold (N)

Department of Gynaecology and Obstetrics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.

Grazia Artioli (G)

ULSS 3 Serenissima, U.O.C. Oncologia ed Ematologia Oncologica, Mirano, Venice, Italy.

Brita Arver (B)

Department of Oncology, Karolinska Institutet, Stockholm, Sweden.

Bernd Auber (B)

Institute of Human Genetics, Hannover Medical School, Hannover, Germany.

Jacopo Azzollini (J)

Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Judith Balmaña (J)

High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Barcelona, Spain.

Rosa B Barkardottir (RB)

Department of Pathology, Landspitali University Hospital, 101, Reykjavik, Iceland.
BMC (Biomedical Centre), Faculty of Medicine, University of Iceland, Reykjavik, Iceland.

Daniel R Barnes (DR)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Alicia Barroso (A)

Human Genetics Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.

Daniel Barrowdale (D)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Muriel Belotti (M)

Service de Génétique, Institut Curie, Paris, France.

Javier Benitez (J)

Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.

Birgitte Bertelsen (B)

Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Marinus J Blok (MJ)

Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, the Netherlands.

Istvan Bodrogi (I)

Department of Chemotherapy, National Institute of Oncology, Budapest, Hungary.

Valérie Bonadona (V)

Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France.

Bernardo Bonanni (B)

Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Davide Bondavalli (D)

Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Susanne E Boonen (SE)

Clinical Genetic Unit, Department of Paediatrics, Zealand University Hospital, Roskilde, Denmark.

Julika Borde (J)

Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.

Ake Borg (A)

Department of Oncology, Lund University and Skåne University Hospital, Lund, Sweden.

Angela R Bradbury (AR)

Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Angela Brady (A)

North West Thames Regional Genetics Service, Kennedy Galton Centre, The North West London Hospitals NHS Trust, Middlesex, United Kingdom.

Carole Brewer (C)

Department of Clinical Genetics, Royal Devon & Exeter Hospital, Exeter, United Kingdom.

Joan Brunet (J)

Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, CIBERONC, Girona, Spain.

Bruno Buecher (B)

Service de Génétique, Institut Curie, Paris, France.

Saundra S Buys (SS)

Department of Medicine, Huntsman Cancer Institute, Salt Lake City, Utah.

Santiago Cabezas-Camarero (S)

Department of Oncology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain.

Trinidad Caldés (T)

Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Almuth Caliebe (A)

Institute of Human Genetics, University Hospital of Schleswig-Holstein, Campus Kiel, Christian-Albrechts University Kiel, Kiel, Germany.

Maria A Caligo (MA)

Section of Molecular Genetics, Department of Laboratory Medicine, University Hospital of Pisa, Pisa, Italy.

Mariarosaria Calvello (M)

Division of Cancer Prevention and Genetics, IEO, European Institute of Oncology IRCCS, Milan, Italy.

Ian G Campbell (IG)

Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

Ileana Carnevali (I)

UO Anatomia Patologica, Ospedale di Circolo-Università dell'Insubria, Varese, Italy.

Estela Carrasco (E)

High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Barcelona, Spain.

Tsun L Chan (TL)

Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong.
Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.

Annie T W Chu (ATW)

Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong.

Wendy K Chung (WK)

Departments of Pediatrics and Medicine, Columbia University, New York, New York.

Kathleen B M Claes (KBM)

Centre for Medical Genetics, Ghent University, Ghent, Belgium.

Gemo Study Collaborators (GS)

Service de Génétique, Institut Curie, Paris, France.

Embrace Collaborators (E)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Jackie Cook (J)

Sheffield Clinical Genetics Service, Sheffield Children's Hospital, Sheffield, United Kingdom.

Laura Cortesi (L)

Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy.

Fergus J Couch (FJ)

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.

Mary B Daly (MB)

Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Giuseppe Damante (G)

Department of Medical and Biological Sciences, University of Udine, Udine, Italy.

Esther Darder (E)

Genetic Counseling Unit, Hereditary Cancer Program, IDIBGI (Institut d'Investigació Biomèdica de Girona), Catalan Institute of Oncology, CIBERONC, Girona, Spain.

Rosemarie Davidson (R)

Department of Clinical Genetics, South Glasgow University Hospitals, Glasgow, United Kingdom.

Miguel de la Hoya (M)

Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Lara Della Puppa (LD)

Division of Functional Onco-genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.

Joe Dennis (J)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Orland Díez (O)

Oncogenetics Group, Clinical and Molecular Genetics Area, Vall d'Hebron Institute of Oncology (VHIO), University Hospital, Barcelona, Spain.

Yuan Chun Ding (YC)

Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California.

Nina Ditsch (N)

Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich, Munich, Germany.

Susan M Domchek (SM)

Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Alan Donaldson (A)

Clinical Genetics Department, St Michael's Hospital, Bristol, United Kingdom.

Bernd Dworniczak (B)

Institute of Human Genetics, University of Münster, Münster, Germany.

Douglas F Easton (DF)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.
Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, United Kingdom.

Diana M Eccles (DM)

Cancer Sciences Academic Unit, Faculty of Medicine, University of Southampton, Southampton, United Kingdom.

Rosalind A Eeles (RA)

Oncogenetics Team, The Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom.

Hans Ehrencrona (H)

Department of Clinical Genetics, Lund University Hospital, Lund, Sweden.

Bent Ejlertsen (B)

Department of Oncology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Christoph Engel (C)

Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
LIFE - Leipzig Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany.

D Gareth Evans (DG)

Division of Evolution and Genomic Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health and Manchester Academic Health Science Centre, University of Manchester, Manchester, United Kingdom.
Manchester Centre for Genomic Medicine, St Mary's Hospital, Central Manchester University Hospitals NHS Foundation Trust and Manchester Academic Health Science Centre, Manchester, United Kingdom.

Laurence Faivre (L)

Unité d'oncogénétique, Centre de Lutte Contre le Cancer, Centre Georges-François Leclerc, Dijon, France.

Ulrike Faust (U)

Institute of Medical Genetics and Applied Genomics, University of Tübingen, Tübingen, Germany.

Lídia Feliubadaló (L)

Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.

Lenka Foretova (L)

Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.

Florentia Fostira (F)

Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research "Demokritos", Athens, Greece.

George Fountzilas (G)

Second Department of Medical Oncology, EUROMEDICA General Clinic of Thessaloniki, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece.

Debra Frost (D)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Vanesa García-Barberán (V)

Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Pilar Garre (P)

Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Marion Gauthier-Villars (M)

Service de Génétique, Institut Curie, Paris, France.

Lajos Géczi (L)

Department of Chemotherapy, National Institute of Oncology, Budapest, Hungary.

Andrea Gehrig (A)

Centre of Familial Breast and Ovarian Cancer, Department of Medical Genetics, Institute of Human Genetics, University of Würzburg, Würzburg, Germany.

Anne-Marie Gerdes (AM)

Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark.

Paul Gesta (P)

Service Régional Oncogénétique Poitou-Charentes, CH Niort, Niort, France.

Giuseppe Giannini (G)

Department of Molecular Medicine, University La Sapienza, Rome, Italy.

Gord Glendon (G)

Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum Research Institute of Mount Sinai Hospital, Toronto, Ontario, Canada.

Andrew K Godwin (AK)

Department of Pathology and Laboratory Medicine, Kansas University Medical Center, Kansas City, Kansas.

David E Goldgar (DE)

Department of Dermatology, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah.

Mark H Greene (MH)

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.

Angelica M Gutierrez-Barrera (AM)

Department of Breast Medical Oncology and Clinical Genetics Program, University of Texas MD Anderson Cancer Center, Houston, Texas.

Eric Hahnen (E)

Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.

Ute Hamann (U)

Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Jan Hauke (J)

Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.

Natalie Herold (N)

Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.

Frans B L Hogervorst (FBL)

Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.

Ellen Honisch (E)

Department of Gynecology and Obstetrics, University Hospital Düsseldorf, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany.

John L Hopper (JL)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.

Peter J Hulick (PJ)

Center for Medical Genetics, NorthShore University HealthSystem, Evanston, Illinois.
The University of Chicago Pritzker School of Medicine, Chicago, Illinois.

KConFab Investigators (K)

Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.
Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.

Hebon Investigators (H)

The Hereditary Breast and Ovarian Cancer Research Group Netherlands (HEBON), Coordinating center: The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Louise Izatt (L)

Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.

Agnes Jager (A)

Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

Paul James (P)

Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.

Ramunas Janavicius (R)

Hematology, Oncology and Transfusion Medicine Center, Department of Molecular and Regenerative Medicine, Vilnius University Hospital Santariskiu Clinics, Vilnius, Lithuania.

Uffe Birk Jensen (UB)

Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.

Thomas Dyrso Jensen (TD)

Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.

Oskar Th Johannsson (OT)

Department of Oncology, Landspitali University Hospital, Reykjavik, Iceland.

Esther M John (EM)

Division of Oncology, Department of Medicine, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California.

Vijai Joseph (V)

Clinical Genetics Research Lab, Department of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, New York.

Eunyoung Kang (E)

Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.

Karin Kast (K)

Department of Gynecology and Obstetrics, Technical University of Dresden, Dresden, Germany.

Johanna I Kiiski (JI)

Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Sung-Won Kim (SW)

Department of Surgery, Daerim Saint Mary's Hospital, Seoul, Korea.

Zisun Kim (Z)

Department of Surgery, Soonchunhyang University Bucheon Hospital, Bucheon, Korea.

Kwang-Pil Ko (KP)

Department of Preventive Medicine, Gacheon University College of Medicine, Incheon, Republic of Korea.

Irene Konstantopoulou (I)

Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research "Demokritos", Athens, Greece.

Gero Kramer (G)

Department of Urology, Medical University of Vienna, Vienna, Austria.

Lotte Krogh (L)

Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.

Torben A Kruse (TA)

Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.

Ava Kwong (A)

Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong.
Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong.
Department of Surgery, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.

Mirjam Larsen (M)

Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.

Christine Lasset (C)

Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France.

Charlotte Lautrup (C)

Department of Clinical Genetics, Aalborg University Hospital, Aalborg, Denmark.

Conxi Lazaro (C)

Molecular Diagnostic Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.

Jihyoun Lee (J)

Department of Surgery, Soonchunhyang University College of Medicine and Soonchunhyang University Hospital, Seoul, Korea.

Jong Won Lee (JW)

Department of Surgery, Ulsan University College of Medicine and Asan Medical Center, Seoul, Korea.

Min Hyuk Lee (MH)

Department of Surgery, Soonchunhyang University College of Medicine and Soonchunhyang University Hospital, Seoul, Korea.

Johannes Lemke (J)

Institute of Human Genetics, University Hospital Leipzig, Leipzig, Germany.

Fabienne Lesueur (F)

Service de Génétique, Institut Curie, Paris, France.
Genetic Epidemiology of Cancer Team, Inserm U900, Paris, France.
Institut Curie, Paris, France.
Mines ParisTech, Fontainebleau, France.

Annelie Liljegren (A)

Department of Oncology, Karolinska Institutet, Stockholm, Sweden.

Annika Lindblom (A)

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden.

Patricia Llovet (P)

Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Adria Lopez-Fernández (A)

High Risk and Cancer Prevention Group, Vall d'Hebron Institute of Oncology, University Hospital Vall d'Hebron, Barcelona, Spain.

Irene Lopez-Perolio (I)

Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Victor Lorca (V)

Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria San Carlos (IdISSC), Centro Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain.

Jennifer T Loud (JT)

Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland.

Edmond S K Ma (ESK)

Hong Kong Hereditary Breast Cancer Family Registry, Cancer Genetics Centre, Happy Valley, Hong Kong.
Department of Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong.

Phuong L Mai (PL)

Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Siranoush Manoukian (S)

Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Veronique Mari (V)

Département d'Hématologie-Oncologie Médicale, Centre Antoine Lacassagne, Nice, France.

Lynn Martin (L)

Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.

Laura Matricardi (L)

Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.

Noura Mebirouk (N)

Service de Génétique, Institut Curie, Paris, France.
Genetic Epidemiology of Cancer Team, Inserm U900, Paris, France.
Institut Curie, Paris, France.
Mines ParisTech, Fontainebleau, France.

Veronica Medici (V)

Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy.

Hanne E J Meijers-Heijboer (HEJ)

Department of Clinical Genetics, VU University Medical Center, Amsterdam, the Netherlands.

Alfons Meindl (A)

Department of Gynecology and Obstetrics, Ludwig Maximilian University of Munich, Munich, Germany.

Arjen R Mensenkamp (AR)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, the Netherlands.

Clare Miller (C)

Department of Clinical Genetics, Alder Hey Hospital, Liverpool, United Kingdom.

Denise Molina Gomes (DM)

Service de Biologie de la Reproduction, Cytogénétique et Génétique Médicale, CHI Poissy - Saint Germain, Poissy, France.

Marco Montagna (M)

Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.

Thea M Mooij (TM)

Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Lidia Moserle (L)

Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.

Emmanuelle Mouret-Fourme (E)

Service de Génétique, Institut Curie, Paris, France.

Anna Marie Mulligan (AM)

Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Laboratory Medicine Program, University Health Network, Toronto, Ontario, Canada.

Katherine L Nathanson (KL)

Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Marie Navratilova (M)

Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.

Heli Nevanlinna (H)

Department of Obstetrics and Gynecology, Helsinki University Hospital, University of Helsinki, Helsinki, Finland.

Dieter Niederacher (D)

Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria, Australia.

Finn C Cilius Nielsen (FCC)

Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Liene Nikitina-Zake (L)

Latvian Biomedical Research and Study Centre, Riga, Latvia.

Kenneth Offit (K)

Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea.
Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.

Edith Olah (E)

Department of Molecular Genetics, National Institute of Oncology, Budapest, Hungary.

Olufunmilayo I Olopade (OI)

Center for Clinical Cancer Genetics, The University of Chicago, Chicago, Illinois.

Kai-Ren Ong (KR)

West Midlands Regional Genetics Service, Birmingham Women's Hospital Healthcare NHS Trust, Birmingham, United Kingdom.

Ana Osorio (A)

Human Cancer Genetics Programme, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
Biomedical Network on Rare Diseases (CIBERER), Madrid, Spain.

Claus-Eric Ott (CE)

Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Domenico Palli (D)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.

Sue K Park (SK)

Department of Preventive Medicine, Seoul National University College of Medicine, Seoul, Korea.
Department of Biomedical Sciences, Seoul National University Graduate School, Seoul, Korea.
Cancer Research Institute, Seoul National University, Seoul, Korea.

Michael T Parsons (MT)

Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Inge Sokilde Pedersen (IS)

Section of Molecular Diagnostics, Clinical Biochemistry, Aalborg University Hospital, Aalborg, Denmark.

Bernard Peissel (B)

Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Ana Peixoto (A)

Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.

Pedro Pérez-Segura (P)

Department of Oncology, Hospital Clinico San Carlos, IdISSC, Madrid, Spain.

Paolo Peterlongo (P)

Genome Diagnostics Program, IFOM - the FIRC (Italian Foundation for Cancer Research) Institute of Molecular Oncology, Milan, Italy.

Annabeth Høgh Petersen (AH)

Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.

Mary E Porteous (ME)

South East of Scotland Regional Genetics Service, Western General Hospital, Edinburgh, United Kingdom.

Miguel Angel Pujana (MA)

Translational Research Laboratory, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.

Paolo Radice (P)

Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, in Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy.

Juliane Ramser (J)

Division of Gynaecology and Obstetrics, Klinikum rechts der Isar der Technischen Universität München, Munich, Germany.

Johanna Rantala (J)

Clinical Genetics, Karolinska Institutet, Stockholm, Sweden.

Muhammad U Rashid (MU)

Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Department of Basic Sciences, Shaukat Khanum Memorial Cancer Hospital and Research Centre (SKMCH & RC), Lahore, Pakistan.

Kerstin Rhiem (K)

Center for Integrated Oncology (CIO), University Hospital of Cologne, Cologne, Germany.
Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.

Piera Rizzolo (P)

Department of Molecular Medicine, University La Sapienza, Rome, Italy.

Mark E Robson (ME)

Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York.

Matti A Rookus (MA)

Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Caroline M Rossing (CM)

Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Kathryn J Ruddy (KJ)

Department of Oncology, Mayo Clinic, Rochester, Minnesota.

Catarina Santos (C)

Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.

Claire Saule (C)

Service de Génétique, Institut Curie, Paris, France.

Rosa Scarpitta (R)

Section of Genetic Oncology, Department of Laboratory Medicine, University and University Hospital of Pisa, Pisa, Italy.

Rita K Schmutzler (RK)

Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.

Hélène Schuster (H)

Unité d'Oncogénétique, Centre de Lutte Contre le Cancer Paul Strauss, Strasbourg, France.

Leigha Senter (L)

Clinical Cancer Genetics Program, Division of Human Genetics, Department of Internal Medicine, The Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio.

Caroline M Seynaeve (CM)

Department of Medical Oncology, Family Cancer Clinic, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.

Payal D Shah (PD)

Department of Medicine, Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

Priyanka Sharma (P)

Department of Internal Medicine, Division of Oncology, University of Kansas Medical Center, Westwood, Kansas.

Vivian Y Shin (VY)

Department of Surgery, The University of Hong Kong, Pok Fu Lam, Hong Kong.

Valentina Silvestri (V)

Department of Molecular Medicine, University La Sapienza, Rome, Italy.

Jacques Simard (J)

Genomics Center, Centre Hospitalier Universitaire de Québec - Université Laval, Research Centre, Québec City, Québec, Canada.

Christian F Singer (CF)

Dept of OB/GYN and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.

Anne-Bine Skytte (AB)

Department of Clinical Genetics, Vejle Hospital, Vejle, Denmark.

Katie Snape (K)

Medical Genetics Unit, St George's, University of London, London, United Kingdom.

Angela R Solano (AR)

INBIOMED, Faculty of Medicine/CONICET and CEMIC, Department of Clinical Chemistry, Medical Direction, University of Buenos Aires, Buenos Aires, Argentina.

Penny Soucy (P)

Department of Internal Medicine, Division of Oncology, University of Kansas Medical Center, Westwood, Kansas.

Melissa C Southey (MC)

Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Victoria, Australia.
Department of Clinical Pathology, The University of Melbourne, Melbourne, Victoria, Australia.

Amanda B Spurdle (AB)

Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Linda Steele (L)

Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California.

Doris Steinemann (D)

Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany.

Dominique Stoppa-Lyonnet (D)

Service de Génétique, Institut Curie, Paris, France.
Department of Tumour Biology, INSERM U830, Paris, France.
Université Paris Descartes, Paris, France.

Agostina Stradella (A)

Genetic Counseling Unit, Hereditary Cancer Program, IDIBELL (Bellvitge Biomedical Research Institute), Catalan Institute of Oncology, CIBERONC, Barcelona, Spain.

Lone Sunde (L)

Department of Clinical Genetics, Aarhus University Hospital, Aarhus, Denmark.

Christian Sutter (C)

Institute of Human Genetics, University Hospital Heidelberg, Heidelberg, Germany.

Yen Y Tan (YY)

Department of OB/GYN, Medical University of Vienna, Vienna, Austria.

Manuel R Teixeira (MR)

Department of Genetics, Portuguese Oncology Institute, Porto, Portugal.
Biomedical Sciences Institute (ICBAS), University of Porto, Porto, Portugal.

Soo Hwang Teo (SH)

Cancer Research Malaysia, Subang Jaya, Selangor, Malaysia.
Breast Cancer Research Unit, Cancer Research Institute, University Malaya Medical Centre, Kuala Lumpur, Malaysia.

Mads Thomassen (M)

Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.

Maria Grazia Tibiletti (MG)

UO Anatomia Patologica, Ospedale di Circolo-Università dell'Insubria, Varese, Italy.

Marc Tischkowitz (M)

Program in Cancer Genetics, Departments of Human Genetics and Oncology, McGill University, Montréal, Quebec, Canada.
Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.

Silvia Tognazzo (S)

Immunology and Molecular Oncology Unit, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy.

Amanda E Toland (AE)

Department of Cancer Biology and Genetics, The Ohio State University, Columbus, Ohio.

Stefania Tommasi (S)

Istituto Nazionale Tumori 'Giovanni Paolo II, Bari, Italy.

Diana Torres (D)

Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota, Colombia.

Angela Toss (A)

Department of Oncology and Haematology, University of Modena and Reggio Emilia, Modena, Italy.

Alison H Trainer (AH)

Parkville Familial Cancer Centre, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.

Nadine Tung (N)

Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.

Christi J van Asperen (CJ)

Department of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.

Frederieke H van der Baan (FH)

Department of Epidemiology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

Lizet E van der Kolk (LE)

Family Cancer Clinic, The Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.

Rob B van der Luijt (RB)

Department of Medical Genetics, University Medical Center, Utrecht, the Netherlands.

Liselotte P van Hest (LP)

Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.

Liliana Varesco (L)

Unit of Hereditary Cancer, Department of Epidemiology, Prevention and Special Functions, IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) AOU San Martino, IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy.

Raymonda Varon-Mateeva (R)

Institute for Medical Genetics and Human Genetics, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Alessandra Viel (A)

Division of Functional Onco-genomics and Genetics, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy.

Jeroen Vierstraete (J)

Centre for Medical Genetics, Ghent University, Ghent, Belgium.

Roberta Villa (R)

Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Anna von Wachenfeldt (A)

Department of Oncology, Karolinska Institutet, Stockholm, Sweden.

Philipp Wagner (P)

Department of Women's Health, Tubingen University Hospital, Tubingen, Germany.

Shan Wang-Gohrke (S)

Department of Gynaecology and Obstetrics, University Hospital Ulm, Ulm, Germany.

Barbara Wappenschmidt (B)

Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
Center for Hereditary Breast and Ovarian Cancer, University Hospital of Cologne, Cologne, Germany.

Jeffrey N Weitzel (JN)

Clinical Cancer Genetics, City of Hope, Duarte, California.

Greet Wieme (G)

Centre for Medical Genetics, Ghent University, Ghent, Belgium.

Siddhartha Yadav (S)

Department of Oncology, Mayo Clinic, Rochester, Minnesota.

Drakoulis Yannoukakos (D)

Molecular Diagnostics Laboratory, INRASTES, National Centre for Scientific Research "Demokritos", Athens, Greece.

Sook-Yee Yoon (SY)

Cancer Research Initiatives Foundation, Sime Darby Medical Centre, Subang Jaya, Selangor, Malaysia.

Cristina Zanzottera (C)

Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Kristin K Zorn (KK)

Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.

Anthony V D'Amico (AV)

Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.

Matthew L Freedman (ML)

Dana-Farber Cancer Institute. Boston, Massachusetts.

Mark M Pomerantz (MM)

Dana-Farber Cancer Institute. Boston, Massachusetts.

Georgia Chenevix-Trench (G)

Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.

Antonis C Antoniou (AC)

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom.

Susan L Neuhausen (SL)

Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, California.

Laura Ottini (L)

Department of Molecular Medicine, University La Sapienza, Rome, Italy.

Henriette Roed Nielsen (HR)

Department of Clinical Genetics, Odense University Hospital, Odense, Denmark.

Timothy R Rebbeck (TR)

Harvard T.H. Chan School of Public Health, Boston, Massachusetts. Timothy_Rebbeck@dfci.harvard.edu.
Dana-Farber Cancer Institute. Boston, Massachusetts.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH